139 related articles for article (PubMed ID: 20426703)
1. Transdermal menopausal hormone therapy: delivery through skin changes the rules.
Buster JE
Expert Opin Pharmacother; 2010 Jun; 11(9):1489-99. PubMed ID: 20426703
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Henzl MR; Loomba PK
J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
[TBL] [Abstract][Full Text] [Related]
3. Transdermal estradiol and testosterone transfer in man: existence, models, and strategies for prevention.
Busse KL; Maibach HI
Skin Pharmacol Physiol; 2011; 24(2):57-66. PubMed ID: 21088452
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle delivery for transdermal HRT.
Valenzuela P; Simon JA
Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
[TBL] [Abstract][Full Text] [Related]
5. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
[TBL] [Abstract][Full Text] [Related]
6. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women.
Shifren JL; Desindes S; McIlwain M; Doros G; Mazer NA
Menopause; 2007; 14(6):985-94. PubMed ID: 17507833
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
Sendağ F; Terek MC; Karadadaş N; Bilgin O
J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
[TBL] [Abstract][Full Text] [Related]
9. Transdermal estrogen and prevention of osteoporosis.
Filer WD; Filer RB
Am Fam Physician; 1994 May; 49(7):1639-44. PubMed ID: 8184798
[TBL] [Abstract][Full Text] [Related]
10. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.
Panay N; Al-Azzawi F; Bouchard C; Davis SR; Eden J; Lodhi I; Rees M; Rodenberg CA; Rymer J; Schwenkhagen A; Sturdee DW
Climacteric; 2010 Apr; 13(2):121-31. PubMed ID: 20166859
[TBL] [Abstract][Full Text] [Related]
11. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy.
Brincat M; Versi E; Moniz CF; Magos A; de Trafford J; Studd JW
Obstet Gynecol; 1987 Jul; 70(1):123-7. PubMed ID: 3601260
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle delivery for transdermal HRT.
Valenzuela P; Simon JA
Maturitas; 2012 Sep; 73(1):74-80. PubMed ID: 22325243
[TBL] [Abstract][Full Text] [Related]
13. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
Balfour JA; Heel RC
Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
[TBL] [Abstract][Full Text] [Related]
14. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
Perrone G; Falaschi P; Capri O; Pastore R; Galoppi P; D'Urso R; Martocchia A; Anelli G; Zichella L
Int J Fertil Menopausal Stud; 1994; 39(4):202-7. PubMed ID: 7951402
[TBL] [Abstract][Full Text] [Related]
15. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
Gambrell RD; Natrajan PK
Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
[TBL] [Abstract][Full Text] [Related]
16. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
17. [Oral or transdermal estrogen substitution therapy in climacteric?].
Runnebaum B; Salbach B; von Holst T
Geburtshilfe Frauenheilkd; 1994 Mar; 54(3):119-30. PubMed ID: 8188009
[TBL] [Abstract][Full Text] [Related]
18. Estrogen replacement therapy and the estraderm transdermal system.
Youngkin EQ
Nurse Pract; 1990 May; 15(5):19-26, 31. PubMed ID: 2342664
[TBL] [Abstract][Full Text] [Related]
19. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
Baker VL
Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
[TBL] [Abstract][Full Text] [Related]
20. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
